of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Chief Accounting Officer and Principal Accounting Officer — Irene Becklund: Ms. Becklund resigned from her roles as Chief Accounting Officer and Principal Accounting Officer.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information described above under

Entry Into a Material Definitive Agreement Receivables Purchase Agreement On July 1, 2026, XeCare LLC and Apostrophe Pharmacy LLC (collectively, the “ Sellers ”), subsidiaries of Hims & Hers Health, Inc. (the “ Company ”), entered into a Master Receivables Purchase Agreement (the “ RPA ”) with JPMorgan Chase Bank, N.A., as purchaser (in such capacity, the “ Purchaser ”). Pursuant to the RPA, the Sellers may from time to time offer to sell to the Purchaser certain eligible receivables for cash…

Other Events On June 2, 2026, the Company issued a press release announcing the completion of its previously announced acquisition of Eucalyptus. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Entry Into a Material Definitive Agreement On May 29, 2026, Hims & Hers Health, Inc. (the “ Company ”), as borrower, entered into Amendment No. 3 (the “ Amendment ”) to the Revolving Credit and Guaranty Agreement, dated as of February 18, 2025 (as amended by that certain Amendment No. 1 to the Revolving Credit and Guaranty Agreement, dated as of June 25, 2025, that certain Amendment No. 2 to the Revolving Credit and Guaranty Agreement, dated as of May 7, 2026, and as amended by this Amendment…

Creation of a Direct Financial Obligation or an Obligation under an Off-balance Sheet Arrangement of a Registrant The information described above under

The Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act, in transactions not involving any public offering. The Notes were resold by the initial purchasers to persons whom the initial purchasers reasonably believe are “qualified institutional buyers,” as defined in, and in accordance with, Rule 144A under the Securities Act. Any shares of the Company’s Class A common stock that may be issued upon conversion of the Notes will be issued in reliance…

Entry Into a Material Definitive Agreement. Indenture and Notes On May 21, 2026, the Company issued $402.5 million aggregate principal amount of Notes. The Notes were issued pursuant to, and are governed by, an indenture (the “ Indenture ”), dated as of May 21, 2026, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”). The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and…

Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant. The disclosure set forth in

Other Events. On May 18, 2026, Hims & Hers Health, Inc. (the “ Company ”) issued a press release relating to its proposed private offering of Convertible Senior Notes due 2032 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “ Securities Act ”). A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this

of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Results of Operations and Financial Condition. On February 23, 2026 , Hims & Hers Health, Inc. (the “Company”) issued a press release and a shareholder letter announcing its results of operations for the quarter and year ended December 31, 2025. Copies of the press release and the shareholder letter are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated by reference in this

Unregistered Sales of Equity Securities. The information set forth under

Entry into a Material Definitive Agreement. On February 19, 2026, Hims & Hers Health, Inc. (the “ Company ”), Hims, Inc. (the “ Guarantor ”), and Horizon BidCo Pty Ltd ACN 694 778 375, an Australian proprietary company (the “ Purchaser ”) and wholly-owned subsidiary of the Company, entered into a Securities Sale Deed (the “ Deed ”) with the sellers party thereto (the “ Sellers ”), pursuant to which, among other things, the Sellers agreed to sell and Purchaser agreed to purchase from each Sell…

Other Events On November 13, 2025, the Board of Directors of Hims & Hers Health, Inc. (the “Company”) authorized and approved a new share repurchase program (the “2025 Share Repurchase Program”) pursuant to which the Company may repurchase up to $250.0 million of its Class A common stock. The 2025 Share Repurchase Program expires on November 11, 2028. The Company intends to use the 2025 Share Repurchase Program to repurchase shares on a discretionary basis from time to time, subject to genera…

of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Chief Operating Officer — Nader Kabbani: Nader Kabbani is transitioning to an advisory role, and Mike Chi is being promoted to Chief Operating Officer.

Entry into a Material Definitive Agreement. On September 1, 2025 (the “Lease Commencement Date”), Hims, Inc. (“Hims”), a wholly-owned subsidiary of Hims & Hers Health, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with Mendel New Albany Property Owner LLC (the “Landlord”) for the lease of approximately 352,012 square feet of space located at 9885 Innovation Campus Way, New Albany, Ohio (the “Premises”). The Company will use the Premises for office, research and development…

of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

The Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act, in transactions not involving any public offering. The Notes were resold by the initial purchasers to persons whom the initial purchasers reasonably believe are “qualified institutional buyers,” as defined in, and in accordance with, Rule 144A under the Securities Act. Any shares of the Company’s Class A common stock that may be issued upon conversion of the Notes will be issued in reliance…

Entry Into a Material Definitive Agreement. Indenture and Notes On May 13, 2025, the Company issued $1.0 billion aggregate principal amount of Notes. The Notes were issued pursuant to, and are governed by, an indenture (the “ Indenture ”), dated as of May 13, 2025, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”). The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and fu…

Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant. The disclosure set forth in

Other Events. On May 8, 2025, Hims & Hers Health, Inc. (the “ Company ”) issued a press release relating to its proposed private offering of Convertible Senior Notes due 2030 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “ Securities Act ”). A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this

of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.